RapidAI’s Lastest Version of Rapid ICH Cleared

FDA has cleared a RapidAI 510(k) for the latest release of Rapid ICH, an intracranial hemorrhage (ICH) triage and notification product. The company says the latest version improves on its technology that supports physicians’ ability to address intracranial hemorrhagic management more accurately and comprehensively than other available products on the market. “While Rapid ICH uses artificial intelligence to quickly analyze non-contrast CT (NCCT) scans and notify clinicians of possible hemorrhage, Rapid Hyperdensity then provides physicians with a more refined view by automatically quantifying and characterizing tissue to identify the location and volume of hyperdense regions,” it says. “The latest release of Rapid ICH essentially eliminates false positives and gives physicians a high degree of confidence to make critical decisions about patients with acute brain hemorrhages.”